Industry News
Nexvet picks up a $1.5m CA grant
Commercialisation Australia will award Nexvet a further $1.5m in grant funding to help the company bring its PETisation technology to market. [ + ]
Recipients of 2013 SIEF grants announced
Australia's Chief Scientist, Professor Ian Chubb, this week honoured the 2013 recipients of the Science and Industry Endowment Fund (SIEF) grants to science and scientists. [ + ]
ReCell vitiligo trial hits recruitment goal
A clinical trial involving using Avita Medical’s (ASX:AVH) ReCell Spray-on Skin to treat skin pigment disorders has hit its 10-patient recruitment goal. [ + ]
GTG signs with new US PPO for BREVAGen
Genetic Technologies (ASX:GTG) has arranged for insurance claims for its BREVAGen breast cancer risk test to be adjudicated in-network with an eighth US PPO. [ + ]
Industry invests in university Chair
A new research Chair at the ANU will be funded by Sirtex Medical. [ + ]
Sitting too much?
Findings of the 12-year AusDiab follow-up study show that Australians aren’t making the lifestyle changes needed to address obesity, high blood pressure and diabetes. [ + ]
Prima cleared to extend cancer trial to Korea
Prima BioMed (ASX:PRR) has received approval to extend its CANVAS cancer vaccine study to South Korea, the first Asian country to be involved in the phase II/III trial. [ + ]
Automated identification of 193 human illness initiators
In the US, the Food and Drug Administration has allowed marketing of the bioMérieux VITEK mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans. [ + ]
Familial DNA searches may misidentify family members
Research published in the journal PLOS ONE, conducted by Rori Rohlfs and colleagues from the University of California at Berkeley and New York University, indicates that familial search methods may identify distant relatives as being closer to the perpetrator than they actually are. [ + ]
AusBiotech welcomes new venture capital fund for biotech
AusBiotech has commended the Labor government’s response to the Strategic Review of Health and Medical Research (The McKeon Review) and its pledge to establish the $250 million Medical Research Innovation Fund (MRIF). [ + ]
iSonea wins Frost innovation award
Frost & Sullivan has handed iSonea (ASX:ISN) an Innovation Leadership Award for its AsthmaSense cloud mobile health-monitoring technology. [ + ]
Academy welcomes Greens' science policy
The Australian Academy of Science has welcomed the commitments made by the Australian Greens in their science policy, released today. The academy is calling on all parties to articulate a strategic approach to science policy. [ + ]
Innovation fund for health and medical research
The Australian Government has committed to growing investment in the health and medical research sector with the Medical Research Innovation Fund. [ + ]
Alchemia earns record fondaparinux profit in Q4
Alchemia (ASX:ACL) said sales of its generic fondaparinux anticoagulant recovered in the June quarter to reach record levels. [ + ]
Nominations invited for 2013 Industry Excellence Awards
Janssen and AusBiotech are delighted to announce that the Janssen 2013 Industry Excellence Awards are now open for nominations. The awards, which have three categories, will be announced at AusBiotech 2013 in Brisbane on 30 October. [ + ]
